All Posts

What HappenedIn June 2025, ASX-listed Mayne Pharma confirmed the sale of its U.S. dermatology business to Cosette Pharmaceuticals for US$450 million (~A$672 million).

In May 2025, Lendlease and Mitsubishi Estate confirmed a joint venture worth A$2.5 billion to co-develop two key commercial towers in Sydney’s CBD

In May 2025, Coforge Technologies Australia — part of global IT services firm Coforge — acquired TMLabs

In June 2025, Pacific Equity Partners completed a A$1.1 billion buyout of Johns Lyng, a leading Australian provider of strata and restoration services.

ADNOC’s recent $30 billion bid for Australia’s Santos isn’t just a headline—it’s a tectonic shift in how sovereign funds influence the region’s strategic assets.

A Conversation with Rachel Bevans, Managing Director, Strategy at The Healthy Brand Company

A conversation with a Nate Richardson, the Strategy & Operations Director at Papermill Agency

A conversation with David Spires, Strategy Director at Landini Associates

Deal flow in 2025 has a pattern: fragmentation + tailwinds = consolidation target. Here are three sectors flashing hot.

The BCG Matrix was revolutionary in its day: simple, visual, strategic. But it's struggling to explain modern businesses.

he companies outperforming in 2025 don’t have one killer product or secret sauce, they have well-constructed, layered capability stacks.

When Definity Financial acquired Travelers Canada for $2.4 billion last week, it wasn’t just a land grab.

Diversification, once derided as bloated and directionless, is regaining credibility in boardrooms.

Salesforce's recent $8 billion acquisition of Informatica isn't just another big-ticket enterprise deal.